That’s why Lilly, Roche, Biontech & Co are investing billions

Other top industry representatives also say that the long-tense relationship between politics and the pharmaceutical industry has improved. Hagen Pfundner, the pharmaceutical boss at Roche Germany, has also experienced the dark times. “We as the pharmaceutical industry have already asked ourselves whether we and our added value are still wanted here in Germany,” says Pfundner, who also led the pharmaceutical industry association VfA for many years. “We are only prepared to invest if the framework conditions are reliable.”